Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Reduces Aggressiveness of Cervical Carcinoma Cells. Wehbe S, Gallwas J, Grundker C. Anticancer Res 2025;45:1793-1805.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wehbe S, Gallwas J, Grundker C. Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Reduces Aggressiveness of Cervical Carcinoma Cells. Anticancer Res 2025;45:1793-1805.
PMID: 40295051